These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11694315)

  • 1. Expression of Fas ligand by microglia: possible role in glioma immune evasion.
    Badie B; Schartner J; Prabakaran S; Paul J; Vorpahl J
    J Neuroimmunol; 2001 Nov; 120(1-2):19-24. PubMed ID: 11694315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired capacity for upregulation of MHC class II in tumor-associated microglia.
    Schartner JM; Hagar AR; Van Handel M; Zhang L; Nadkarni N; Badie B
    Glia; 2005 Sep; 51(4):279-85. PubMed ID: 15818597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
    Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
    Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversial role of microglia in malignant gliomas.
    Wei J; Gabrusiewicz K; Heimberger A
    Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and central nervous system immunity.
    Kaur G; Han SJ; Yang I; Crane C
    Neurosurg Clin N Am; 2010 Jan; 21(1):43-51. PubMed ID: 19944965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro.
    Badie B; Schartner J; Vorpahl J; Preston K
    Exp Neurol; 2000 Apr; 162(2):290-6. PubMed ID: 10739635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas.
    Badie B; Bartley B; Schartner J
    J Neuroimmunol; 2002 Dec; 133(1-2):39-45. PubMed ID: 12446006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis.
    Roth W; Isenmann S; Nakamura M; Platten M; Wick W; Kleihues P; Bähr M; Ohgaki H; Ashkenazi A; Weller M
    Cancer Res; 2001 Mar; 61(6):2759-65. PubMed ID: 11289159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.
    Badie B; Schartner JM; Paul J; Bartley BA; Vorpahl J; Preston JK
    J Neurosurg; 2000 Oct; 93(4):634-9. PubMed ID: 11014542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
    Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
    J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of central and peripheral immunomodulation in a murine glioma model.
    Kennedy BC; Maier LM; D'Amico R; Mandigo CE; Fontana EJ; Waziri A; Assanah MC; Canoll P; Anderson RC; Anderson DE; Bruce JN
    BMC Immunol; 2009 Feb; 10():11. PubMed ID: 19226468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
    Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
    Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors.
    Ichinose M; Masuoka J; Shiraishi T; Mineta T; Tabuchi K
    Brain Tumor Pathol; 2001; 18(1):37-42. PubMed ID: 11517972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
    Wu A; Wei J; Kong LY; Wang Y; Priebe W; Qiao W; Sawaya R; Heimberger AB
    Neuro Oncol; 2010 Nov; 12(11):1113-25. PubMed ID: 20667896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE; Shanahan F; O'Connell J; Houston AM
    Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.
    Carvalho da Fonseca AC; Wang H; Fan H; Chen X; Zhang I; Zhang L; Lima FR; Badie B
    J Neuroimmunol; 2014 Sep; 274(1-2):71-7. PubMed ID: 25042352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microglia in central nervous system immunity and glioma immunology.
    Yang I; Han SJ; Kaur G; Crane C; Parsa AT
    J Clin Neurosci; 2010 Jan; 17(1):6-10. PubMed ID: 19926287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.